With the introduction of stringent data minimization regulations, organizations must adapt to ensure compliance while maintaining trust and transparency. These regulations aim to protect individual privacy by limiting the amount of personal data collected, stored, and processed.

In an age where data is as valuable as currency, the ability for data companies to manage and manipulate this asset with agility and precision is crucial. This is especially pertinent in the healthcare industry, where the integrity and flexibility of data management systems directly impact privacy, and regulatory compliance.

Today, digital advancements are intertwined with every facet of our daily lives. Given the dynamic, fast-changing environment, the healthcare industry stands at a crucial intersection of technology and patient care.

President Biden issued an Executive Order on Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern, targeting transfers of bulk sensitive data to countries of concern. Under the Order, sensitive data is defined to include genomic data, biometric data, personal health data, geolocation data, financial data, and certain personal identifiers.

Successful compliance with increasingly strict and regularly changing data privacy laws requires effective consent management processes. Advertising technology companies, pharma companies and their agencies must obtain explicit consent to use protected sensitive information. Knowing what that entails can be challenging since additional new laws will come on the books in 2024 and beyond.

In the evolving landscape of digital advertising, particularly in the healthcare space, staying ahead of the curve in terms of compliance and best practices is not just an advantage – it's a necessity.